Clinical Trial Update: Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device [Phase 3]

View source ↗

Summary

Phase 3 clinical evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device by LivaNova has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• PARADYM CRT Device (Physiological Diagnosis Function)

Snippet

Sponsor: LivaNova | Conditions: Heart Failure | Phase 3 | Status: COMPLETED